• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码核胆汁酸受体FXR的NR1H4基因的遗传变异与炎症性肠病的关联。

Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease.

作者信息

Attinkara Ragam, Mwinyi Jessica, Truninger Kaspar, Regula Jaroslaw, Gaj Pawel, Rogler Gerhard, Kullak-Ublick Gerd A, Eloranta Jyrki J

机构信息

Department of Clinical Pharmacology and Toxicology, University Hospital, Zurich, Switzerland.

出版信息

BMC Res Notes. 2012 Aug 28;5:461. doi: 10.1186/1756-0500-5-461.

DOI:10.1186/1756-0500-5-461
PMID:22929053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3517390/
Abstract

BACKGROUND

Pathogenesis of inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD), involves interaction between environmental factors and inappropriate immune responses in the intestine of genetically predisposed individuals. Bile acids and their nuclear receptor, FXR, regulate inflammatory responses and barrier function in the intestinal tract.

METHODS

We studied the association of five variants (rs3863377, rs7138843, rs56163822, rs35724, rs10860603) of the NR1H4 gene encoding FXR with IBD. 1138 individuals (591 non-IBD, 203 UC, 344 CD) were genotyped for five NR1H4 genetic variants with TaqMan SNP Genotyping Assays.

RESULTS

We observed that the NR1H4 SNP rs3863377 is significantly less frequent in IBD cases than in non-IBD controls (allele frequencies: P = 0.004; wild-type vs. SNP carrier genotype frequencies: P = 0.008), whereas the variant rs56163822 is less prevalent in non-IBD controls (allele frequencies: P = 0.027; wild-type vs. SNP carrier genotype frequencies: P = 0.035). The global haplotype distribution between IBD and control patients was significantly different (P = 0.003). This also held true for the comparison between non-IBD and UC groups (P = 0.004), but not for the comparison between non-IBD and CD groups (P = 0.079).

CONCLUSIONS

We show that genetic variation in FXR is associated with IBD, further emphasizing the link between bile acid signaling and intestinal inflammation.

摘要

背景

炎症性肠病(IBD),包括溃疡性结肠炎(UC)和克罗恩病(CD),其发病机制涉及环境因素与遗传易感性个体肠道中不适当免疫反应之间的相互作用。胆汁酸及其核受体FXR可调节肠道中的炎症反应和屏障功能。

方法

我们研究了编码FXR的NR1H4基因的五个变体(rs3863377、rs7138843、rs56163822、rs35724、rs10860603)与IBD的关联。采用TaqMan SNP基因分型检测法对1138名个体(591名非IBD患者、203名UC患者、344名CD患者)的五个NR1H4基因变体进行基因分型。

结果

我们观察到,IBD患者中NR1H4 SNP rs3863377的频率显著低于非IBD对照(等位基因频率:P = 0.004;野生型与SNP携带者基因型频率:P = 0.008),而变体rs56163822在非IBD对照中不太常见(等位基因频率:P = 0.027;野生型与SNP携带者基因型频率:P = 0.035)。IBD患者与对照患者之间的总体单倍型分布存在显著差异(P = 0.003)。非IBD组与UC组之间的比较也是如此(P = 0.004),但非IBD组与CD组之间的比较则不然(P = 0.079)。

结论

我们表明FXR的基因变异与IBD相关,进一步强调了胆汁酸信号传导与肠道炎症之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b98e/3517390/6b03eef80a58/1756-0500-5-461-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b98e/3517390/6b03eef80a58/1756-0500-5-461-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b98e/3517390/6b03eef80a58/1756-0500-5-461-1.jpg

相似文献

1
Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease.编码核胆汁酸受体FXR的NR1H4基因的遗传变异与炎症性肠病的关联。
BMC Res Notes. 2012 Aug 28;5:461. doi: 10.1186/1756-0500-5-461.
2
Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.常见维生素 D 结合蛋白多态性与炎症性肠病的关联。
Pharmacogenet Genomics. 2011 Sep;21(9):559-64. doi: 10.1097/FPC.0b013e328348f70c.
3
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.NOD2/CARD15和Toll样受体4基因单核苷酸多态性在炎症性肠病中的临床意义
World J Gastroenterol. 2008 Jul 28;14(28):4454-61. doi: 10.3748/wjg.14.4454.
4
Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population.人类潘氏细胞防御素A5中的单核苷酸多态性可能使新西兰白种人群易患炎症性肠病。
Dig Liver Dis. 2008 Sep;40(9):723-30. doi: 10.1016/j.dld.2008.02.011. Epub 2008 Apr 3.
5
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.法尼醇 X 受体 (FXR) 在炎症性肠病中的激活和 FXR 遗传变异。
PLoS One. 2011;6(8):e23745. doi: 10.1371/journal.pone.0023745. Epub 2011 Aug 22.
6
MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.MDR1 基因多态性与塞尔维亚炎症性肠病患者队列中的溃疡性结肠炎相关。
PLoS One. 2018 Mar 15;13(3):e0194536. doi: 10.1371/journal.pone.0194536. eCollection 2018.
7
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.神经肽S受体1基因多态性与炎症性肠病易感性相关。
Gastroenterology. 2007 Sep;133(3):808-17. doi: 10.1053/j.gastro.2007.06.012. Epub 2007 Jun 20.
8
[Association of inflammatory bowel disease with the polymorphisms and haplotypes of fucosyltransferase 3 gene].炎症性肠病与岩藻糖基转移酶3基因多态性及单倍型的关联
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Dec;32(6):849-54. doi: 10.3760/cma.j.issn.1003-9406.2015.06.022.
9
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.DLG5基因变异不会影响苏格兰人群患炎症性肠病的易感性。
Gut. 2005 Oct;54(10):1416-20. doi: 10.1136/gut.2005.066621. Epub 2005 Apr 20.
10
Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?炎症性肠病患者ABCB1基因(C3435T)的基因多态性。是否存在性别依赖性?
Pharmacol Rep. 2015 Apr;67(2):294-8. doi: 10.1016/j.pharep.2014.09.014. Epub 2014 Oct 18.

引用本文的文献

1
Effects of Several Bile Acids on the Production of Virulence Factors by .几种胆汁酸对……毒力因子产生的影响
Life (Basel). 2024 Dec 18;14(12):1676. doi: 10.3390/life14121676.
2
Roles of and polymorphisms in the susceptibility to antituberculosis drug-induced liver injury in China: a case‒control study.基因多态性在中国抗结核药物性肝损伤易感性中的作用:一项病例对照研究。
Front Genet. 2024 Oct 23;15:1428319. doi: 10.3389/fgene.2024.1428319. eCollection 2024.
3
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development.

本文引用的文献

1
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.法尼醇 X 受体 (FXR) 在炎症性肠病中的激活和 FXR 遗传变异。
PLoS One. 2011;6(8):e23745. doi: 10.1371/journal.pone.0023745. Epub 2011 Aug 22.
2
Genetic factors in the pathogenesis of cholangiocarcinoma.胆管癌发病机制中的遗传因素。
Dig Dis. 2011;29(1):93-7. doi: 10.1159/000324688. Epub 2011 Jun 17.
3
A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.一种新的 NR1H4 终止密码子杂合突变导致特发性婴儿胆汁淤积症。
胆汁酸信号在代谢和炎症性疾病及药物研发中的作用
Pharmacol Rev. 2024 Oct 16;76(6):1221-1253. doi: 10.1124/pharmrev.124.000978.
4
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.胆汁酸与肠道炎症的相互作用影响炎症性肠病的发病机制。
Intern Emerg Med. 2023 Nov;18(8):2181-2197. doi: 10.1007/s11739-023-03343-3. Epub 2023 Jul 29.
5
Comparative transcriptomics from intestinal cells of permissive and non-permissive hosts during infection reveals unique signatures of protection and host specificity.在感染过程中,允许和不允许宿主的肠道细胞的比较转录组学揭示了保护和宿主特异性的独特特征。
Parasitology. 2023 May;150(6):511-523. doi: 10.1017/S0031182023000227. Epub 2023 Mar 8.
6
Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.胆汁酸与微生物组:在克罗恩病中,解析它们在作用和管理方面的这种动态关系。
Can J Gastroenterol Hepatol. 2022 Mar 22;2022:8416578. doi: 10.1155/2022/8416578. eCollection 2022.
7
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.胆汁酸在炎症性肠病发病机制中的新作用。
Front Immunol. 2022 Feb 3;13:829525. doi: 10.3389/fimmu.2022.829525. eCollection 2022.
8
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.胆汁酸及其受体在胃肠道和肝脏病理生理学中的作用。
Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):432-450. doi: 10.1038/s41575-021-00566-7. Epub 2022 Feb 14.
9
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity.肠肝轴法尼醇 X 受体(FXR)的病理生理学:炎症、屏障功能和先天免疫。
Cells. 2021 Nov 17;10(11):3206. doi: 10.3390/cells10113206.
10
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.肠道微生物群失调对炎症性肠病的代谢影响
Front Physiol. 2021 Sep 27;12:715506. doi: 10.3389/fphys.2021.715506. eCollection 2021.
World J Pediatr. 2012 Feb;8(1):67-71. doi: 10.1007/s12519-011-0299-z. Epub 2011 Jun 1.
4
Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.法尼醇 X 受体可保护人类和鼠类胃上皮细胞免受炎症诱导的损伤。
Biochem J. 2011 Sep 1;438(2):315-23. doi: 10.1042/BJ20102096.
5
Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine.促炎细胞因子激活肠道中的NF-κB信号通路,从而抑制胆盐核受体FXR的激活。
Biochim Biophys Acta. 2011 Aug;1812(8):851-8. doi: 10.1016/j.bbadis.2011.04.005. Epub 2011 Apr 22.
6
Nuclear receptors as new perspective for the management of liver diseases.核受体作为肝脏疾病治疗新视角。
Gastroenterology. 2011 Apr;140(4):1120-1125.e1-12. doi: 10.1053/j.gastro.2011.02.044. Epub 2011 Feb 18.
7
FXR activation inhibits inflammation and preserves the intestinal barrier in IBD.法尼醇X受体(FXR)激活可抑制炎症并维持炎症性肠病(IBD)中的肠道屏障。
Gut. 2011 Apr;60(4):432-3. doi: 10.1136/gut.2010.233304. Epub 2011 Jan 26.
8
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.法尼醇 X 受体激活可抑制炎症并维持炎症性肠病的肠道屏障。
Gut. 2011 Apr;60(4):463-72. doi: 10.1136/gut.2010.212159. Epub 2011 Jan 17.
9
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.全基因组荟萃分析将确认的克罗恩病易感性位点数量增加到 71 个。
Nat Genet. 2010 Dec;42(12):1118-25. doi: 10.1038/ng.717.
10
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.炎症性肠病相关的肝胆胰管表现和并发症。
Inflamm Bowel Dis. 2010 Sep;16(9):1598-619. doi: 10.1002/ibd.21219.